Cargando…
Novel Characteristics of Trypanosoma brucei Guanosine 5'-monophosphate Reductase Distinct from Host Animals
The metabolic pathway of purine nucleotides in parasitic protozoa is a potent drug target for treatment of parasitemia. Guanosine 5’-monophosphate reductase (GMPR), which catalyzes the deamination of guanosine 5’-monophosphate (GMP) to inosine 5’-monophosphate (IMP), plays an important role in the i...
Autores principales: | Bessho, Tomoaki, Okada, Tetsuya, Kimura, Chihiro, Shinohara, Takahiro, Tomiyama, Ai, Imamura, Akira, Kuwamura, Mitsuru, Nishimura, Kazuhiko, Fujimori, Ko, Shuto, Satoshi, Ishibashi, Osamu, Kubata, Bruno Kilunga, Inui, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701174/ https://www.ncbi.nlm.nih.gov/pubmed/26731263 http://dx.doi.org/10.1371/journal.pntd.0004339 |
Ejemplares similares
-
Allosteric regulation accompanied by oligomeric state changes of Trypanosoma brucei GMP reductase through cystathionine-β-synthase domain
por: Imamura, Akira, et al.
Publicado: (2020) -
Identification of a Novel Prostaglandin F(2α) Synthase in Trypanosoma brucei
por: Kubata, Bruno Kilunga, et al.
Publicado: (2000) -
Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s disease
por: Liu, Hongde, et al.
Publicado: (2018) -
Temperature and pressure limits of guanosine monophosphate self-assemblies
por: Gao, Mimi, et al.
Publicado: (2017) -
Investigation of Trypanothione Reductase as a Drug Target in Trypanosoma brucei
por: Spinks, Daniel, et al.
Publicado: (2009)